| mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.8 |
| mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.011 |
0.8 |
| mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.8 |
| mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.0099 |
0.9 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |